Vanda Pharmaceuticals | VNDA - Acreedores Comerciales





Acreedores Comerciales Cambio Fecha
Acadia Pharmaceuticals USD 44.57M 32.32M 2026-06
Agios Pharmaceuticals USD 16.34M 2.6M 2026-06
Akebia Therapeutics USD 9.42M 1.04M 2026-06
Alnylam Pharmaceuticals USD 108.02M 18.61M 2026-06
Anika Therapeutics USD 6.24M 103K 2026-06
Arrowhead Research USD 27.78M 2.97M 2026-06
AstraZeneca USD 22.89B 388M 2026-06
Bristol-Myers Squibb USD 4.16B 76M 2026-06
Eli Lilly USD 6.11B 1.08B 2026-06
Enanta Pharmaceuticals USD 1.88M 63K 2025-12
Halozyme Therapeutics USD 23.61M 9.51M 2026-06
Heron Therapeutics USD 11.64M 2.67M 2026-06
Insmed USD 74.55M 1.18M 2026-06
J&J USD 9.22B 1.24B 2026-06
Lexicon Pharmaceuticals USD 3M 87K 2026-03
Ligand Pharmaceuticals USD 9.4M 27.7M 2026-06
Merck USD 3.83B 36M 2026-06
Minerva Neurosciences USD 640K 305K 2025-12
Moderna USD 167M 6M 2026-06
Novartis USD 4.32B 134M 2026-03
Pfizer USD 4.58B 75M 2026-06
PTC Therapeutics USD 40.45M 14.96M 2026-06
Puma Biotechnology USD 6.39M 962K 2025-09
Sangamo BioSciences USD 10.74M 7.46M 2025-06
Sanofi EUR 23.6B 888M 2026-06
Takeda JPY 446.78B 44.56B 2026-06
Teva Pharmaceutical Industries USD 2.72B 125M 2026-06
Ultragenyx Pharmaceutical USD 39M 3M 2026-06
Vanda Pharmaceuticals USD 39.09M 33.28M 2024-12
Veracyte USD 8.02M 1.12M 2026-06